CD8A and neoplasm: For example, CXCR3 and its ligand CXCL9 were critical for a productive CD8+ T cell response in tumor-bearing mice treated with anti-PD-1, indicating that the CXCR3 chemokine system was an indicator of the clinical sensitivity to anti-PD-1 mAb.